Surgery Stock Analysis

SGRY
 Stock
  

USD 28.56  0.25  0.88%   

The current bullish price patterns experienced by current Surgery Partners shareholders created some momentum for investors as it was traded today as low as 27.87 and as high as 29.07 per share. The company management teams have been very successful in rebalancing the company assets at opportune times to take advantage of market volatility in November. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.66. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Surgery Partners partners.
Additionally, take a look at World Market Map.
  
The Surgery Partners stock analysis report makes it easy to digest most publicly released information about Surgery Partners and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Surgery Stock analysis module also helps to analyze the Surgery Partners price relationship with some important fundamental indicators such as market cap and management efficiency.

Surgery Stock Analysis Notes

About 91.0% of the company shares are owned by institutional investors. The book value of Surgery Partners was at this time reported as 13.28. The company has Price/Earnings To Growth (PEG) ratio of 1.66. Surgery Partners recorded a loss per share of 0.47. The entity had not issued any dividends in recent years. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people. To find out more about Surgery Partners contact Michael Doyle at 615 234 5900 or learn more at https://www.surgerypartners.com.

Surgery Partners Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Surgery Partners' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgery Partners or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Surgery Partners has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 2.23 B. Net Loss for the year was (70.9 M) with profit before overhead, payroll, taxes, and interest of 491.4 M.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Hendrix Blair E of 9183673 shares of Surgery Partners subject to Rule 16b-3

Surgery Partners Upcoming and Recent Events

Earnings reports are used by Surgery Partners to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgery Partners previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report9th of March 2022
Next Financial Report4th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End9th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Surgery Largest EPS Surprises

Earnings surprises can significantly impact Surgery Partners' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-02
2022-06-30-0.01-0.03-0.02200 
2020-03-05
2019-12-310.120.1-0.0216 
2016-08-09
2016-06-300.140.160.0214 
View All Earnings Estimates

Surgery Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 3.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgery Partners's market, we take the total number of its shares issued and multiply it by Surgery Partners's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Surgery Profitablity

Surgery Partners' profitability indicators refer to fundamental financial ratios that showcase Surgery Partners' ability to generate income relative to its revenue or operating costs. If, let's say, Surgery Partners is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Surgery Partners' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Surgery Partners' profitability requires more research than a typical breakdown of Surgery Partners' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.14 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.0.
Last ReportedProjected for 2022
Return on Investment 7.88  8.46 
Return on Average Assets(1.23) (1.33) 
Return on Average Equity(8.65) (8.88) 
Return on Invested Capital(0.0322) (0.0331) 
Return on Sales(0.06) (0.06) 

Management Efficiency

The entity has return on total asset (ROA) of 0.0358 % which means that it generated profit of $0.0358 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.0495 %, meaning that it created $0.0495 on every $100 dollars invested by stockholders. Surgery Partners management efficiency ratios could be used to measure how well surgery partners manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to rise to 8.46 in 2022, whereas Return on Average Assets are likely to drop (1.33)  in 2022. Surgery Partners Total Assets are fairly stable at the moment as compared to the past year. Surgery Partners reported Total Assets of 6.12 Billion in 2021. Current Assets is likely to rise to about 1 B in 2022, whereas Assets Non Current are likely to drop slightly above 1.4 B in 2022.
Last ReportedProjected for 2022
Book Value per Share(0.13) (0.14) 
Enterprise Value over EBIT(44.10) (47.58) 
Enterprise Value over EBITDA(174.24) (187.99) 
Price to Book Value(220.47) (237.88) 
Tangible Assets Book Value per Share 16.04  14.45 
Enterprise Value2.1 B2.1 B
Tangible Asset Value578.7 M494.8 M

Technical Drivers

As of the 2nd of December, Surgery Partners has the Semi Deviation of 4.57, coefficient of variation of 2917.73, and Risk Adjusted Performance of 0.0589. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgery Partners, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Surgery Partners, which can be compared to its competition. Please validate Surgery Partners information ratio and downside variance to decide if Surgery Partners is priced more or less accurately, providing market reflects its prevalent price of 28.56 per share. Given that Surgery Partners has jensen alpha of (0.12), we advise you to double-check Surgery Partners's current market performance to make sure the company can sustain itself at a future point.

Surgery Partners Price Movement Analysis

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Triangular Moving Average shows Surgery Partners double smoothed mean price over a specified number of previous prices (i.e., averaged twice).
.

Surgery Partners Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgery Partners insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgery Partners' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgery Partners insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Surgery Partners Predictive Daily Indicators

Surgery Partners intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgery Partners stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Surgery Partners Forecast Models

Surgery Partners time-series forecasting models is one of many Surgery Partners' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgery Partners' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Surgery Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgery Partners prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgery shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Surgery Partners. By using and applying Surgery Stock analysis, traders can create a robust methodology for identifying Surgery entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 13.17  14.81 
EBITDA Margin 17.32  19.07 
Gross Margin 22.08  28.07 
Profit Margin(3.19) (3.44) 

Current Surgery Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgery analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgery analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
62.11Buy9Odds
Surgery Partners current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Surgery analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgery stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgery Partners, talking to its executives and customers, or listening to Surgery conference calls.
Surgery Analyst Advice Details

Surgery Stock Analysis Indicators

Surgery Partners stock analysis indicators help investors evaluate how Surgery Partners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgery Partners shares will generate the highest return on investment. By understating and applying Surgery Partners stock analysis, traders can identify Surgery Partners position entry and exit signals to maximize returns.
Begin Period Cash Flow318200000.00
Total Stockholder Equity1089000000.00
Country NameUSA
Capital Lease Obligations355700000.00
Property Plant And Equipment Net953800000.00
Retained Earnings-502700000.00
Cash And Short Term Investments389900000.00
Retained Earnings Total Equity-502700000.00
Cash389900000.00
50 Day M A26.0402
Net Interest Income-221000000.00
Total Current Liabilities536800000.00
Forward Price Earnings42.735
Common Stock Total Equity900000.00
Logo U R LimglogosUSSGRY.png
Common Stock Shares Outstanding48776000.00
Total Cashflows From Investing Activities-331700000.00
Tax Provision10500000.00
Warrants330200000.00
CodeSGRY
Accounts Payable124900000.00
Net Debt2548100000.00
Currency CodeUSD
Other Operating Expenses1898600000.00
Non Current Assets Total5171500000.00
Liabilities And Stockholders Equity7206600000.00
Non Currrent Assets Other59100000.00
Additionally, take a look at World Market Map. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for analysis

When running Surgery Partners price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.3 B
Quarterly Revenue Growth YOY
0.11
Return On Assets
0.0358
Return On Equity
0.0495
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine Surgery Partners value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.